Monthly Archives: July 2020
Acute on Chronic Liver Failure – Possibly the main culprit of increased mortality in COVID-19 patients with liver disease
COVID-19, ACEI/ARBs and gastrointestinal symptoms: the jury is still out on the association.
NEW: VUMC to recruit up to 1,000 volunteers for COVID-19 vaccine trial
In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Instit… Continue reading
NEW: VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Continue reading
NEW: Guidance on outpatients who previously tested positive or report exposure to COVID-19
With the continued spread of COVID-19 in the community and for the protection of VUMC staff, faculty, patients and visitors it is important for VUMC to know if patients have previously tested positive or been exposed to COVID-19. Continue reading
NEW: Antibody research at VUMC shows promise in fight against COVID-19
Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. Continue reading
REMINDER: N95 users can sterilize masks for reuse
N95s are typically discarded after a single use but the threat of supply shortages have prompted hospitals around the U.S. to adopt sterilization procedures that allow reuse. Continue reading
NEW: Guidance for use of eye protection from COVID
With the rise in incidence of COVID-19, the CDC and Tennessee Department of Health have enhanced the recommended PPE to include eye protection (e.g. face shields, goggles, eye shields) for all direct patient encounters. Continue reading
Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with intestinal dysbiosis. Given reported promising results of open-label fecal microbiota transplantation (FMT) therapy in patients with predominant abdominal bloating… Continue reading